• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降钙素基因相关肽和肾上腺髓质素受体的胞外结构域。

Ectodomain structures of the CGRP and AM receptors.

机构信息

RIKEN Systems and Structural Biology Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.

出版信息

Curr Protein Pept Sci. 2013 Aug;14(5):375-85. doi: 10.2174/13892037113149990054.

DOI:10.2174/13892037113149990054
PMID:23745701
Abstract

Receptor activity-modifying proteins (RAMPs) 1-3, which are classified as type I transmembrane proteins, serve as the partner proteins of several family B GPCRs for physiologically active peptides, including the calcitonin receptor- like receptor (CLR). The properties of the GPCRs are defined by the RAMP and peptide ligand combination. The CLR•RAMP1 heterodimer functions mainly as the calcitonin gene-related peptide (CGRP) receptor, while the CLR•RAMP2 and CLR•RAMP3 heterodimers primarily function as the adrenomedullin 1 and adrenomedullin 2 (AM₁ and AM₂) receptors, respectively. The crystal structures of the RAMP1 and RAMP2 ectodomains exhibited three-helix bundles, and those of their complexes with the N-terminal extracellular domain of CLR revealed how the two ectodomains associate to form the CGRP and AM₁ receptors, respectively. On this structural framework, the various intermolecular interactions of CLR with RAMP1 and RAMP2 result in the distinct shapes of the putative ligand-binding sites, where several residues are uniquely presented. Therefore, the differences in the shapes and the presented residues of the binding sites determine the specificities of the receptors to either CGRP or AM. These structural features of the ectodomains are consistent with mutagenesis results, and are useful to further examine the binding modes of the peptide ligands to the full-length CGRP and AM₁ receptors.

摘要

受体活性修饰蛋白(RAMPs)1-3 被归类为 I 型跨膜蛋白,作为几种 B 族 G 蛋白偶联受体(GPCR)的伴侣蛋白,为生理活性肽提供服务,包括降钙素受体样受体(CLR)。GPCR 的特性由 RAMP 和肽配体的组合决定。CLR•RAMP1 异二聚体主要作为降钙素基因相关肽(CGRP)受体发挥作用,而 CLR•RAMP2 和 CLR•RAMP3 异二聚体主要作为肾上腺髓质素 1(AM₁)和肾上腺髓质素 2(AM₂)受体发挥作用。RAMP1 和 RAMP2 外结构域的晶体结构呈现出三螺旋束,其与 CLR 的 N 端细胞外结构域复合物的结构揭示了两个外结构域如何分别形成 CGRP 和 AM₁ 受体。在这个结构框架上,CLR 与 RAMP1 和 RAMP2 的各种分子间相互作用导致了假定的配体结合位点的独特形状,其中有几个独特的残基呈现出来。因此,结合位点的形状和呈现出来的残基的差异决定了受体对 CGRP 或 AM 的特异性。这些外结构域的结构特征与突变结果一致,有助于进一步研究全长 CGRP 和 AM₁ 受体中肽配体的结合模式。

相似文献

1
Ectodomain structures of the CGRP and AM receptors.降钙素基因相关肽和肾上腺髓质素受体的胞外结构域。
Curr Protein Pept Sci. 2013 Aug;14(5):375-85. doi: 10.2174/13892037113149990054.
2
Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.受体活性修饰蛋白依赖性突变对降钙素受体样受体的影响:对肾上腺髓质素和降钙素基因相关肽药理学的影响。
Br J Pharmacol. 2014 Feb;171(3):772-88. doi: 10.1111/bph.12508.
3
Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.通过连接的 RAMP-降钙素受体样受体细胞外域融合蛋白对 CGRP 和肾上腺髓质素肽的选择性结合。
Protein Sci. 2013 Dec;22(12):1775-85. doi: 10.1002/pro.2377. Epub 2013 Oct 19.
4
Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.通过合理设计强效肾上腺髓质素和降钙素基因相关肽拮抗剂探究受体活性修饰蛋白对 G 蛋白偶联受体配体选择性的调控机制。
Mol Pharmacol. 2018 Apr;93(4):355-367. doi: 10.1124/mol.117.110916. Epub 2018 Jan 23.
5
Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.外源性肾上腺髓质素和降钙素基因相关肽对Ramp和Calcrl基因缺陷小鼠的心血管作用。
Peptides. 2017 Feb;88:1-7. doi: 10.1016/j.peptides.2016.12.002. Epub 2016 Dec 8.
6
Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.人源 RAMP1 和 RAMP3 第 74 位氨基酸的结构-功能分析及其在肽与肾上腺髓质素和降钙素基因相关肽受体相互作用中的作用。
Peptides. 2011 May;32(5):1060-7. doi: 10.1016/j.peptides.2011.03.004. Epub 2011 Mar 22.
7
Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.肾上腺髓质素和降钙素基因相关肽受体的新型肽拮抗剂:鉴定、药理学特性以及与受体活性修饰蛋白1/3中74位的相互作用
J Pharmacol Exp Ther. 2009 Nov;331(2):513-21. doi: 10.1124/jpet.109.156448. Epub 2009 Jul 30.
8
Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.降钙素基因相关肽和肾上腺髓质素受体与Gs偶联中依赖和不依赖受体活性修饰蛋白的激活机制
Biochem Pharmacol. 2017 Oct 15;142:96-110. doi: 10.1016/j.bcp.2017.07.005. Epub 2017 Jul 11.
9
Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.结构-功能分析揭示了肾上腺髓质素 2/中介素的三 β-转角受体结合构象,并能够设计肽类拮抗剂。
J Biol Chem. 2018 Oct 12;293(41):15840-15854. doi: 10.1074/jbc.RA118.005062. Epub 2018 Aug 23.
10
Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.鉴定对降钙素基因相关肽、肾上腺髓质素和胰淀素受体功能重要的N端受体活性修饰蛋白残基。
Mol Pharmacol. 2008 Oct;74(4):1059-71. doi: 10.1124/mol.108.047142. Epub 2008 Jul 1.

引用本文的文献

1
Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.受体活性调节蛋白(RAMPs):新见解与作用
Annu Rev Pharmacol Toxicol. 2016;56:469-87. doi: 10.1146/annurev-pharmtox-010715-103120. Epub 2015 Oct 23.